Newswise — This week's New York Times' in-depth series, "Bad Blood," about the diabetes epidemic in New York City, is a compelling portrayal of New Yorkers struggling with the increased incidence of this devastating chronic disease. But the epidemic of diabetes is not limited to New York City.
"We at Joslin Diabetes Center applaud The New York Times for shedding light on a disease that has quietly grown to a national epidemic while health officials have focused resources and funding on other, often less prevalent, diseases," says C. Ronald Kahn, M.D., President of Joslin and the Mary K. Iacocca Professor of Medicine at Harvard Medical School. "This series should be a wake-up call to Congress, to public health officials, and to anyone who has yet to realize the seriousness of the disease."
Diabetes strikes everyone, young and old, rich and poor, but especially hits hard certain ethnic groups. This includes African Americans and Latinos (especially Mexican Americans and Puerto Ricans) who develop diabetes nearly twice as often as Caucasians. It also affects Native Americans and Asian Americans at high rates, even though the latter have little obesity. What's more, about one-third of the Americans with diabetes do not even know they have the disease and many have the disease for a decade or more before it's diagnosed.
Joslin Diabetes Center, with more than 100 years of experience researching and treating the disease and with more than 25 affiliates around the nation, can provide a national perspective on the disease that currently affects 21 million Americans and 41 million more who have pre-diabetes. Joslin physicians and researchers can discuss the impact on patients and their families -- especially since many patients are affected by diabetes-related complications like heart disease long before they are diagnosed with diabetes. Joslin experts, including Martin Abrahamson, M.D., Medical Director of Joslin, and James L. Rosenzweig, M.D., Director of Disease Management, are available to advise your viewers and readers on how to manage their diabetes to avoid the devastating complications so starkly presented in the "Bad Blood" series. Dr. Kahn can discuss the enormous looming impact on the healthcare system if the disease is not taken more seriously or with more urgency. Other experts who can comment on the disproportionate impact on ethnic groups include George King, M.D., Research Director, and William Hsu, M.D., both of Joslin's Asian American Diabetes Initiative, and Enrique Caballero, M.D., who heads Joslin's Latino Diabetes Initiative.
About Joslin Diabetes Center
Joslin Diabetes Center, dedicated to conquering diabetes in all of its forms, is the global leader in diabetes research, care and education. Founded in 1898, Joslin is an independent nonprofit institution affiliated with Harvard Medical School. Joslin research is a team of more than 300 people at the forefront of discovery aimed at preventing and curing diabetes. Joslin Clinic, affiliated with Beth Israel Deaconess Medical Center in Boston, the nationwide network of Joslin Affiliated Programs, and the hundreds of Joslin educational programs offered each year for clinicians, researchers and patients, enable Joslin to develop, implement and share innovations that immeasurably improve the lives of people with diabetes. As a nonprofit, Joslin benefits from the generosity of donors in advancing its mission. For more information on diabetes and Joslin, call 1-800-JOSLIN-1 or visit http://www.joslin.org.
RSS